340 related articles for article (PubMed ID: 22653980)
1. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study.
Friberg L; Benson L; Rosenqvist M; Lip GY
BMJ; 2012 May; 344():e3522. PubMed ID: 22653980
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
3. Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation.
Mason PK; Lake DE; DiMarco JP; Ferguson JD; Mangrum JM; Bilchick K; Moorman LP; Moorman JR
Am J Med; 2012 Jun; 125(6):603.e1-6. PubMed ID: 22502952
[TBL] [Abstract][Full Text] [Related]
4. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
[TBL] [Abstract][Full Text] [Related]
5. Risk of Stroke in Atrial Fibrillation According to Sex in Patients Aged Younger Than 75 Years: A Large-Scale, Observational Study Using Real-World Data.
Maeda T; Nishi T; Funakoshi S; Tada K; Tsuji M; Satoh A; Kawazoe M; Yoshimura C; Arima H
Heart Lung Circ; 2021 Jul; 30(7):963-970. PubMed ID: 33468388
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification schemes, anticoagulation use and outcomes: the risk--treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation.
Sandhu RK; Bakal JA; Ezekowitz JA; McAlister FA
Heart; 2011 Dec; 97(24):2046-50. PubMed ID: 22076011
[TBL] [Abstract][Full Text] [Related]
7. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Circulation; 2012 May; 125(19):2298-307. PubMed ID: 22514252
[TBL] [Abstract][Full Text] [Related]
8. Comparison between CHADS2 and CHA2 DS2 -VASc score in a stroke cohort with atrial fibrillation.
Giralt-Steinhauer E; Cuadrado-Godia E; Ois A; Jiménez-Conde J; Rodríguez-Campello Á; Soriano C; Roquer J
Eur J Neurol; 2013 Apr; 20(4):623-8. PubMed ID: 22834861
[TBL] [Abstract][Full Text] [Related]
9. Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA
Nielsen PB; Skjøth F; Overvad TF; Larsen TB; Lip GYH
Circulation; 2018 Feb; 137(8):832-840. PubMed ID: 29459469
[TBL] [Abstract][Full Text] [Related]
10. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.
Olesen JB; Lip GY; Hansen ML; Hansen PR; Tolstrup JS; Lindhardsen J; Selmer C; Ahlehoff O; Olsen AM; Gislason GH; Torp-Pedersen C
BMJ; 2011 Jan; 342():d124. PubMed ID: 21282258
[TBL] [Abstract][Full Text] [Related]
11. Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
Hobbs FD; Roalfe AK; Lip GY; Fletcher K; Fitzmaurice DA; Mant J;
BMJ; 2011 Jun; 342():d3653. PubMed ID: 21700651
[TBL] [Abstract][Full Text] [Related]
12. Alcohol-related hospitalization is associated with increased risk of ischaemic stroke among low-risk patients with atrial fibrillation.
Al-Khalili F; Benson L; Friberg L
Europace; 2018 Jan; 20(1):19-24. PubMed ID: 28339885
[TBL] [Abstract][Full Text] [Related]
13. Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study.
Friberg L; Benson L; Lip GY
Eur Heart J; 2015 Feb; 36(5):297-306. PubMed ID: 24722803
[TBL] [Abstract][Full Text] [Related]
14. CHADS(2) and CHA(2)DS (2)-VASc score of patients with atrial fibrillation or flutter and newly detected left atrial thrombus.
Wasmer K; Köbe J; Dechering D; Milberg P; Pott C; Vogler J; Stypmann J; Waltenberger J; Mönnig G; Breithardt G; Eckardt L
Clin Res Cardiol; 2013 Feb; 102(2):139-44. PubMed ID: 22983022
[TBL] [Abstract][Full Text] [Related]
15. CHA(2)DS(2)-VASc versus CHADS(2) for stroke risk assessment in low-risk patients with atrial fibrillation: a pilot study from a single center of the NCDR-PINNACLE registry.
Piyaskulkaew C; Singh T; Szpunar S; Saravolatz L; Rosman H
J Thromb Thrombolysis; 2014 May; 37(4):400-3. PubMed ID: 23943340
[TBL] [Abstract][Full Text] [Related]
16. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
[TBL] [Abstract][Full Text] [Related]
17. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores.
Cha MJ; Kim YD; Nam HS; Kim J; Lee DH; Heo JH
Eur J Neurol; 2012 Mar; 19(3):473-9. PubMed ID: 21972975
[TBL] [Abstract][Full Text] [Related]
18. Risk of ischemic stroke and utility of CHA
Tomasdottir M; Friberg L; Hijazi Z; Lindbäck J; Oldgren J
Clin Cardiol; 2019 Oct; 42(10):1003-1009. PubMed ID: 31490011
[TBL] [Abstract][Full Text] [Related]
19. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
20. Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population.
Poli D; Lip GY; Antonucci E; Grifoni E; Lane D
J Cardiovasc Electrophysiol; 2011 Jan; 22(1):25-30. PubMed ID: 20653814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
